Promising Publication: The Novel Schizophrenia Treatment Gaining Traction

March 10, 2021
Stephen Brannan, MD

Dr Brannan is chief medical officer at Karuna Therapeutics and a neuroscience drug development expert.

Data published in The New England Journal of Medicine shows promise for a novel schizophrenia treatment.

Stephen Brannan, MD, Chief Medical Officer of Karuna Therapeutics, talks more on the phase II clinical data for KarXT, published in the New England Journal of Medicine.

To read more, see Journal Publication Brings Good News for Novel Schizophrenia Treatment.

Dr Brannan is chief medical officer at Karuna Therapeutics and a neuroscience drug development expert.